[Microbiocenosis of the mucous membranes of the upper respiratory tract and its correction with acipol in the treatment of patients with acute respiratory virus infections].

Clinical and laboratory evaluation of the preparation Acipol in 45 children greatly susceptible to acute respiratory virus infections (ARVI) was carried out. Simultaneously with the clinical analysis, the study of the microflora of the mucous membranes of the upper respiratory tracts and intestine, as well as the levels of secretory IgA in saliva and coprofiltrates before and after treatment, was made. The inclusion of Acipol into the therapy of ARVI patients facilitated their clinical convalescence, uncomplicated course of the disease, correction of disturbances in the biocenosis of the upper respiratory tracts and increased infectious resistance.

[Arbidole--a new drug for prevention of influenza and acute viral respiratory infections in children].

The antiviral drug arbidole reduces influenza and acute respiratory diseases (ARD) in children by 1.5-2 times when given in a dose of 0.1-0.

[The seroepidemiological aspects of respiratory diseases and the prospects for their prevention in organized children's sanatorium-type collectives].

68 children aged 3-7 years, undergoing general sanative treatment in a bronchopulmonary sanatorium in the vicinity of Moscow between November 10 and December 29, 1990, were examined. During the stay of these children in the sanatorium cases of respiratory diseases, mainly of parainfluenza etiology, were registered, which was confirmed by serological laboratory studies. At this season no cases of Legionella and Mycoplasma infections were detected.

[Clinical picture and treatment of Legionella pneumonia in children].

Data on the clinical and laboratory study involving 150 children with the verified diagnosis of pneumonia observed as inpatients within a period from 1984 to 1988 are presented. To elucidate the pneumonia etiology, blood sera to the causative agents of influenza and parainfluenza, adenovirus, RS virus, Mycoplasma pneumoniae and Legionella pneumophila were assayed. An increase in the number of neutralizing antibodies to L.